MedicaidPrior AuthHigh impact
MAB2026070102
Pennsylvania Medicaid (DHS)·PA · Orthopedics, Rheumatology, Sports Medicine +2 more·Provider Bulletin
Effective date
Jul 6, 2026
We identified it
Jul 8, 2026
Summary
Pennsylvania Medical Assistance updated prior authorization requirements for intra-articular hyaluronate injections, effective July 6, 2026. The key change clarifies that renewal requests must document improvement following the MOST RECENT treatment (not the first treatment). All intra-articular hyaluronate prescriptions now require prior authorization; renewals require documented pain/joint function improvement, no prior injection in same joint within 6 months, and failure of preferred agents for non-preferred products.
Action Required
By July 6, 2026: (1) Billing and clinical teams must update prior authorization submission protocols to require documentation of improvement following the MOST RECENT intra-articular hyaluronate treatment (not the first treatment) for all renewal requests. (2) Update PA request templates and clinical documentation checklists to capture: documented improvement in pain or joint function post-treatment, 6-month washout verification for same joint, contraindication screening, and preferred drug list (PDL) failure documentation for non-preferred agents. (3) Train providers and staff that ALL intra-articular hyaluronate prescriptions require prior authorization—no exceptions. (4) Establish workflow to flag renewal requests submitted without documented improvement from most recent treatment and return for additional clinical documentation. (5) Update internal billing system guidance documents. Failure to obtain prior authorization will result in claim denials; claims for renewals without documented improvement from most recent treatment will be denied.